Instructions to Authors  by unknown
The Taiwanese Journal of Obstetrics and Gynecology publishes 
reviews, original articles and short communications in the 
field of obstetrics and gynecology, with the goal of promot-
ing and improving women’s health. It is published quarterly.
The Journal requires authors to be in compliance with the 
Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals (URMs); current URMs are available at http://www.
icmje.org
1. Manuscript Submission
Three copies of the original manuscript, one copy of each of 
the applicable supporting documents detailed in Section 
1.2., and two checklists (available at the end of these author 
instructions) should be addressed to:
Dr Chih-Ping Chen
Editor-in-Chief,
Taiwanese Journal of Obstetrics and Gynecology
Taiwan Association of Obstetrics and Gynecology
5/F, No. 70, Min-Chuan W. Road, Taipei 104,
Taiwan, R.O.C.
Tel: (+ 886) 2-25684819
Fax: (+ 886) 2-21001476
E-mail: cpc_mmh@yahoo.com
1.1. Important Information
	  Articles submitted should be in Microsoft Word docu-
ment format and prepared in the simplest form possible. 
We will add in the correct font, font size, margins and so 
on according to the journal’s style.
  You may use automatic page numbering, but do NOT use 
other kinds of automatic formatting such as footnotes, 
headers and footers.
  Put text, references, and table/figure legends in one file.
  Figures must be submitted separately as picture files, at 
the correct resolution. The files should be named accord-
ing to the figure number and format, e.g., “Fig1.tif”, 
“Fig2.jpg”. Also see section 9.6.
1.2. Supporting Documents
The following documents must be included (refer also 
to the Checklist that follows these author instruc-
tions):
(1)  Cover Letter. This must include the name, address, tele-
phone and fax numbers, and e-mail address of the cor-
responding author.
(2)  Authorship Statement. You may use the form that fol-
lows these author instructions. ALL the authors’ signa-
tures must be included.
(3)  Conflict of Interest Statement. See Section 2 below.
(4)  Ethics Statement. Articles covering human or animal 
experiments must be accompanied by a letter of 
approval from the relevant review committee or authori-
ties. Also see Section 3 below.
(5)  Consolidated Standards of Reporting Trials 
(CONSORT) flow chart for randomized controlled trials 
submitted for publication. Also see Section 4 below.
(6)  Copyright Transfer Agreement. You may use the form 
that follows these author instructions.
(7)  Articles where human subjects can be identified in 
descriptions, photographs or pedigrees must be accom-
panied by a signed statement of informed consent to 
publish (in print and online) the descriptions, photo-
graphs and pedigrees from each subject who can be 
identified. Also see Section 5 below.
(8)  Where material has been reproduced from other copy-
righted sources, the letter(s) of permission from the cop-
yright holder(s) to use the copyrighted sources must be 
supplied.
2. Disclosure of Conflicts of Interest
All authors are required to sign and submit the following 
financial disclosure statement at the time of manuscript sub-
mission:
I certify that all my affiliations with or financial involvement 
in, within the past 5 years and foreseeable future, any organi-
zation or entity with a financial interest in or financial conflict 
with the subject matter or materials discussed in the manu-
script are completely disclosed (e.g., employment, consultan-
cies, honoraria, stock ownership or options, expert testimony, 
grants or patents received or pending, royalties).
Authors who have no relevant financial interests should pro-
vide a statement indicating that they have no financial inter-
ests related to the material in the manuscript. Any 
nonfinancial conflicts of interest should also be explicitly 
declared in your own words.
3. Ethical Approval of Studies and Informed Consent
For human or animal experimental investigations, appropri-
ate institutional review board or ethics committee approval 
is required, and such approval should be stated in the meth-
ods section of the manuscript. For those investigators who 
do not have formal ethics review committees, the principles 
outlined in the Declaration of Helsinki should be followed 
(World Medical Association. Declaration of Helsinki: ethical 
principles for medical research involving human subjects. Available 
at: http://www.wma.net/en/30publications/10policies/b3/
index.html).
For investigations in humans, state explicitly in the meth-
ods section of the manuscript that informed consent was 
obtained from all participating adults and from parents or 
legal guardians for minors or incapacitated adults, together 
with the manner in which informed consent was obtained 
(ex. oral or written).
For work involving experimental animals, the guidelines 
for their care and use should be in accordance with European 
Commission Directive 86/609/EEC for animal experiments (availa-
ble at http://ec.europa.eu/environment/chemicals/lab_animals/ 
Instructions to Authors
legislation_en.htm); this should be stated in the methods 
section of the manuscript.
4. Reporting Clinical Trials
All randomized controlled trials submitted for publication 
should include a completed Consolidated Standards of 
Reporting Trials (CONSORT) flow chart (available at http://
www.consort-statement.org). This Journal has adopted the 
proposal from the International Committee of Medical 
Journal Editors (ICMJE) that require, as a condition of con-
sideration for publication of clinical trials, registration in a 
public trials registry. Purely observational studies (those in 
which the assignment of the medical intervention is not at 
the discretion of the investigator) do not require registration. 
Further information can be found at http://www.icmje.org.
5. Identification of Patients in Descriptions, 
Photographs and Pedigrees
A signed statement of informed consent to publish (in print 
and online) patient descriptions, photographs and pedigrees 
should be obtained from all subjects (parents or legal guard-
ians for minors) who can be identified (including by the sub-
jects themselves) in such written descriptions, photographs 
or pedigrees. Such persons should be shown the manuscript 
before its submission. Omitting data or making data less 
specific to de-identify patients is acceptable, but changing 
any such data is not acceptable.
6. Previous Publication or Duplicate Submission
Submitted manuscripts are considered with the understand-
ing that they have not been published previously in print or 
electronic format (except in abstract or poster form) and are 
not under consideration in totality or in part by another 
publication or electronic medium.
7. Basic Criteria
Articles should be written in English (using American English 
spelling) and meet the following basic criteria: the material is 
original, the information is important, the writing is clear 
and concise, the study methods are appropriate, the data 
are valid, and the conclusions are reasonable and supported 
by the data.
8. Article Categories
8.1. Review Articles
These should aim to provide the reader with a balanced 
overview of an important and topical subject in the field, and 
should be systematic and critical assessments of literature 
and data sources. They should cover aspects of a topic in 
which scientific consensus exists as well as aspects that 
remain controversial and are the subject of ongoing scientific 
research. All articles and data sources reviewed should 
include information about the specific type of study or anal-
ysis, population, intervention, exposure, and tests or out-
comes. All articles or data sources should be selected 
systematically for inclusion in the review and critically evalu-
ated.
Typical length: 2000–4000 words, 50–100 references.
8.2. Original Articles
These may be randomized trials, intervention studies, studies 
of screening and diagnostic tests, laboratory and animal 
studies, cohort studies, cost-effectiveness analyses, case-con-
trol studies, and surveys with high response rates, which rep-
resent new and significant contributions to the field.
Section headings should be: Abstract, Introduction, 
Materials and methods, Results, Discussion, Acknowledgments 
(if applicable), and References.
The Introduction should provide a brief background to 
the subject of the paper, explain the importance of the study, 
and state a precise study question or purpose.
The Materials and methods section should describe the 
study design and methods (including the study setting and 
dates, patients/participants with inclusion and exclusion cri-
teria, or data sources and how these were selected for the 
study, patient samples or animal specimens used, explain 
the laboratory methods followed), and state the statistical 
procedures employed in the research.
The Results section should comprise the study results 
presented in a logical sequence, supplemented by tables 
and/or figures. Take care that the text does not repeat data 
that are presented in tables and/or figures. Only emphasize 
and summarize the essential features of any interventions, 
the main outcome measures, and the main results.
The Discussion section should be used to emphasize the 
new and important aspects of the study, placing the results 
in context with published literature, the implications of the 
findings, and the conclusions that follow from the study 
results.
Typical length: 2000–3000 words, 40–80 references.
8.3. Short Communications
These should be concise presentations of clinical or prelimi-
nary experimental results. Section headings should be: 
Abstract, Introduction, Materials and methods, Results, 
Discussion, Acknowledgments (if applicable), and 
References.
Typical length: 1000–1500 words, 20–40 references, with 
no more than four figures or tables. The Editors reserve the 
right to decide what constitutes a Short Communication.
8.4. Case Reports
These are short discussions of a case or case series with 
unique features not previously described that make an 
important teaching point or scientific observation. They may 
describe novel techniques, novel use of equipment, or new 
information on diseases of importance. Section headings 
should be: Abstract, Introduction, Case Report, Discussion, 
Acknowledgments (if applicable), and References.
The Introduction should describe the purpose of the 
report, the significance of the disease and its specificity, and 
briefly review the relevant literature.
The Case Report should include the general data of the 
case, medical history, family history, chief complaint, present 
illness, clinical manifestation, methods of diagnosis and 
treatment, and outcome.
The Discussion should compare, analyze and discuss the 
similarities and differences between the reported case and 
similar previously reported cases. The importance or specifi-
city of the case should be restated when discussing the dif-
ferential diagnoses. Suggest the prognosis of the disease and 
possibility of prevention.
Typical length: 800–1500 words, 20–40 references.
8.5. Research Letters
These typically include interesting cases that do not meet the 
requirement of being truly exceptional. Typical length: 600–
1000 words, up to 10 references.
8.6. Correspondence
Correspondence is welcome in response to previously 
published articles or relating to a topical subject in the 
field, as well as other communications of general inter-
est. Correspondence should have a title and include 
appropriate references, and include the corresponding 
author’s mailing and e-mail addresses. They are edited, 
sometimes extensively, to sharpen their focus, and they 
may be sent for peer review at the discretion of the 
Editors.
Typical length: 300–600 words, up to 10 references.
8.7. Editorials
Editorials are invited comments concerning a specific paper 
in the Journal or a topical issue in the field. While normally 
invited, unsolicited editorials may be submitted.
Typical length: 1000–1500 words, 15–30 references.
9. Manuscript Preparation
Text should be typed double-spaced on white A4 (297 ¥ 210 
mm) paper, with outer margins of 2.5 cm. A manuscript 
should include a title page, abstract, text, acknowledgments 
(if any), references, and figures and tables as appropriate. 
Each section of the manuscript should begin on a new page. 
Pages should be numbered consecutively, beginning with the 
title page.
9.1. Title Page
The title page should contain the following information (in 
order, from the top to bottom of the page):
 category of paper
 article title
  names (spelled out in full)* of all the authors, and the 
institutions with which they are affiliated; indicate all 
affiliations with a superscript lowercase letter after the 
author’s name and in front of the appropriate affiliation
  corresponding author details (name, e-mail, mailing 
address, telephone and fax numbers)
*The name of each author should be written with the family name 
last, e.g., Jing-Lin Chang. Authorship is restricted only to direct par-
ticipants who have contributed significantly to the work. 
9.2. Abstract and Keywords
The first page following the title page should contain a struc-
tured abstract of no more than 250 words and up to six key-
words listed in alphabetical order.
For Original Articles and Short Communications, the 
abstract should use the following headings: “Objective” 
should state the main purpose of the work; “Materials and 
Methods” should briefly describe the study subjects and out-
line the methods used; “Results” should summarize the most 
important data; and “Conclusion” should briefly state the 
conclusions which are directly supported by the data, along 
with any clinical implications.
For Case Reports, the abstract should use the following 
headings: “Objective” should state the specific purpose of 
the work; “Case Report(s)” should summarize the pertinent 
features of the clinical findings, important laboratory abnor-
malities, treatment, and outcomes; and “Conclusion” 
should summarize the principal findings.
Abstracts for Review Articles should be in a single para-
graph with no section headings.
No abstract or keywords are required for Research 
Letters, Correspondence and Editorials.
9.3. Main Text
The text for Original Articles and Short Communications 
should be organized into the following sections: 
Introduction, Materials and Methods, Results, Discussion, 
and References. The Introduction should discuss the objec-
tive of the reported work and provide relevant background 
information. The Materials and Methods should identify the 
population or patient samples in the study and explain the 
methods used. The Results should explain all the important 
findings and provide information about the accuracy and 
reliability of the results. The Discussion should state the 
implications of the findings and any conclusions based on 
the findings.
The text for Case Reports should be divided into the fol-
lowing sections: Introduction, Case Report(s), Discussion, 
and References.
The text for Review Articles should be divided into logical 
sections with appropriate headings.
The text For Research Letters, Correspondence and 
Editorials should be in one single section with appropriate 
paragraphs, but there should be no section headings.
Please note that writing errors will result in immediate 
rejection of the paper.
9.3.1. Abbreviations
Where a term/definition will be continually referred to, it 
must be written in full when it first appears in the text, fol-
lowed by the subsequent abbreviation in parentheses. 
Thereafter, the abbreviation may be used. An abbreviation 
should not be first defined in any section heading; if an 
abbreviation has previously been defined in the text, then the 
abbreviation may be used in a subsequent section heading. 
Restrict the number of abbreviations to those that are abso-
lutely necessary.
9.3.2. Units
Système International (SI) units must be used, with the 
exception of blood pressure values which are to be reported 
in mmHg. Please use the metric system for the expression of 
length, area, mass, and volume. Temperatures are to be 
given in degrees Celsius.
9.3.3. Names of drugs, devices and other products
Use the Recommended International Non-proprietary Name 
for medicinal substances, unless the specific trade name of a 
drug is directly relevant to the discussion. For devices and 
other products, the generic term should be used, unless the 
specific trade name is directly relevant to the discussion. If 
the trade name is given, then the manufacturer name and 
the city, state and country location of the manufacturer 
must be provided.
9.3.4. Statistical requirements
Statistical analysis is essential for all research papers except 
case reports. Use correct nomenclature of statistical meth-
ods (e.g., two sample t test, not unpaired t test). Descriptive 
statistics should follow the scales used in data description. 
Inferential statistics are important for interpreting results 
and should be described in detail.
All p values should be presented to the third decimal 
place for accuracy, unless they are less than 0.001. The 
smallest p value that should be expressed is p < 0.001, since 
additional zeros do not convey useful information; the larg-
est p value that should be expressed is p > 0.99.
9.3.5. Personal communications and unpublished data
These sources cannot be included in the references list but 
may be described in the text. The author(s) must give the full 
name and highest academic degree of the person, the date of 
the communication, and indicate whether it was in oral or 
written (letter, fax, e-mail) form. A signed statement of per-
mission should be included from each person identified as a 
source of information in a personal communication or as a 
source for unpublished data.
9.3.6. Acknowledgments
General acknowledgments for consultations, statistical anal-
ysis, etc., should be listed concisely at the end of the text, 
including the names of the individuals who were directly 
involved. Consent should be obtained from those individuals 
before their names are listed in this section. All financial and 
material support for the research and work from internal or 
external agencies, including commercial companies, should 
be clearly and completely identified. Ensure that any con-
flicts of interest (financial and/or nonfinancial) are explicitly 
declared.
9.4. References
9.4.1. In the main text, tables, figure legends
  References should be indicated by numbers in square 
brackets in line with the text, and numbered consecu-
tively in order of appearance in the text.
  References cited in tables or figure legends should be 
included in sequence at the point where the table or fig-
ure is first mentioned in the main text.
  Do not cite uncompleted work or work that has not yet 
been accepted for publication (i.e., “unpublished obser-
vation”, “personal communication”) as references. Also 
see Section 9.3.5. above.
  Do not cite abstracts unless they are the only available 
reference to an important concept.
9.4.2. In the references section
  References should be limited to those cited in the text 
and listed in numerical order, NOT alphabetical order.
  References should include, in order, author surnames 
and initials, article title, abbreviated journal name, year, 
volume and inclusive page numbers. The last names and 
initials of all the authors up to 6 should be included, but 
when authors number 7 or more, list the first 6 authors 
only followed by “et al”. Abbreviations for journal names 
should conform to those used in MEDLINE.
  If citing a website, provide the author information, arti-
cle title, website address and the date you accessed the 
information.
  Reference to an article that is in press must state the 
journal name and, if possible, the year and volume.
Authors are responsible for the accuracy and completeness of their ref-
erences and for correct text citation.
Examples are given below.
Standard journal article:
Kanamori C, Kanamori T, Tanaka Y, Kanzaki H. Three-cycle 
fentanyl patch system contributes to stable control of 
plasma fentanyl concentration in gynecologic cancer pain 
patients. Taiwan J Obstet Gynecol 2011;50:79–84.
Journal article with more than 6 authors:
Chen CP, Wu PC, Lin CJ, Chern SR, Tsai FJ, Lee CC, et al. 
Unbalanced reciprocal translocations at aminocentesis. 
Taiwanese J Obstet Gynecol 2011;50:48–57.
Journal supplement:
Kaplan NM. The endothelium as prognostic factor and ther-
apeutic target: what criteria should we apply? J Cardiovasc 
Pharmacol 1998;32(Suppl 3):S78–80.
Journal article not in English but with English abstract:
Nakayama H, Ishikawa T, Yamashita S, Fukui I, Mutoh T, 
Hikichi K, et al. CSF leakage and anosmia in aneurysm clip-
ping of anterior communicating artery by basal interhemi-
spheric approach. No Shinkei Geka 2011;39:263–8. [In 
Japanese, English abstract]
Book:
Bradley EL. Medical and surgical management. Philadelphia: 
Saunders; 1982, p. 72–95.
Book chapter in book with editor and edition:
Greaves M, Culligan DJ. Blood and bone marrow. In: 
Underwood JCE, editor. General and systematic pathology. 
4th ed. London: Churchill Livingstone; 2004, p. 615–72.
Bulletin:
World Health Organization. World health report 2002: 
reducing risk, promoting healthy life. Geneva, Switzerland: 
World Health Organization; 2002.
Company/manufacturer publication/pamphlet:
Eastman Kodak Company, Eastman Organic Chemicals. 
Catalog no. 49. Rochester, NY: Eastman Kodak; 1977, p. 
2–3.
Conference proceedings:
Pacak K, Aguilera G, Sabban E, Kvetnansky R, editors. Stress: 
current neuroendocrine and genetic approaches. 8th sympo-
sium on catecholamines and other neurotransmitters in 
stress, June 28–July 3, 2003, Smolenice Castle, Slovakia. New 
York: New York Academy of Sciences; 2004.
Electronic publications:
Duchin JS. Can preparedness for biological terrorism save us 
from pertussis? Arch Pediatr Adolesc Med 2004;158(2). 
Available from: http://archpedi.ama-assn.org/cgi/content/
full/158/2/106. Accessed June 12, 2004.
Smeeth L, Iliffe S. Community screening for visual impair-
ment in the elderly. Cochrane Database Syst Rev 
2002(2):CD001054. Doi:10.1002/14651858.CD1001054.
Thesis:
Ayers AJ. Retention of resin restorations by means of enamel 
etching and by pins [MSD thesis]. Indianapolis: Indiana 
University; 1971.
Website:
American Association of Oral and Maxillofacial Surgeons. 
Wisdom teeth. AAOMS website. http://www.aaoms.org/
wisdom_teeth.php. Published 2008. Accessed November 
15, 2009.
9.5. Tables
Tables should supplement, not duplicate, the text. They 
should have a concise table heading, be self-explanatory, 
and numbered consecutively in the order of their citation in 
the text. Information requiring explanatory footnotes should 
be denoted using superscripted lowercase letters in alpha-
betical order (a, b, c, etc.). Abbreviations used in the table 
must be defined and placed after the footnotes. If you 
include a block of data or table from another source, 
whether published or unpublished, you must acknowledge 
the original source.
9.6. Figures
9.6.1. General guidelines
The number of figures should be restricted to the minimum 
necessary to support the textual material. They should have 
an informative figure legend and be numbered in the order of 
their citation in the text. All symbols and abbreviations 
should be defined in the legend. Patient identification should 
be obscured. All lettering should be done professionally and 
should be in proportion to the drawing, graph or photo-
graph. Photomicrographs must include an internal scale 
marker, and the legend should state the type of specimen, 
original magnification and stain.
Figures must be submitted as separate picture files at the 
correct resolution (see Section 9.6.2. below). The files 
should be named according to the figure number and for-
mat, e.g., “Fig1.tif”, “Fig2.jpg”.
The cost of printing color figures may be charged to the 
author.
9.6.2. Formats
Regardless of the application used, when your electronic art-
work is finalized, please “save as” or convert the images to 
one of the following formats (note the resolution require-
ments for line drawings, halftones, and line/halftone combi-
nations given below):
  EPS: Vector drawings. Embed the font or save the text as 
“graphics”.
  TIFF: Color or grayscale photographs (halftones): always 
use a minimum of 300 dpi.
  TIFF: Bitmapped line drawings: use a minimum of 1000 
dpi.
  TIFF: Combination of bitmapped line/half-tone (color or 
grayscale): a minimum of 600 dpi is required.
  DOC, XLS or PPT: If your electronic artwork is created in 
any of these Microsoft Office applications, please supply 
“as is”.
Please do not:
  Supply files that are optimized for screen use (like GIF, 
BMP, PICT, WPG); the resolution is too low;
  Supply files that are too low in resolution;
  Submit graphics that are disproportionately large for the 
content.
A detailed guide on electronic artwork is available at http://
www.elsevier.com/artworkinstructions.
10. The Editorial and Peer Review Process
As a general rule, the receipt of a manuscript will be acknowl-
edged within 2 weeks of submission, and authors will be pro-
vided with a manuscript reference number for future 
correspondence. If such an acknowledgment is not received 
in a reasonable period of time, the author should contact 
the Editorial Office.
Submissions are reviewed by the Editorial Office to ensure 
that it contains all parts. The Editorial Office will not accept 
a submission if the author has not supplied all the material 
and documents as outlined in these author instructions.
Manuscripts are then forwarded to the Editor-in-Chief, 
who makes an initial assessment of it. If the manuscript does 
not appear to be of sufficient merit or is not appropriate for 
the Journal, then the manuscript will be rejected without 
review.
Manuscripts that appear meritorious and appropriate for 
the Journal are reviewed by at least two Editorial Board 
members or expert consultants assigned by the Editor-in-
Chief. Authors will usually be notified within 6 weeks of 
whether the submitted article is accepted for publication, 
rejected, or subject to revision before acceptance. However, 
do note that delays are sometimes unavoidable.
Before publication, all manuscripts will be reviewed by a 
native English-speaking editor with a biomedical back-
ground. Manuscripts which require extensive modification 
will be returned for retyping. Fees for English correction must 
be paid by the authors.
11. Preparation for Publication
Once a manuscript has been accepted for publication, the 
authors should submit the final version of the manuscript in 
MS Word format, with all tables/figures as applicable, to the 
Editorial Office.
Accepted manuscripts are copyedited according to the 
Journal’s style and PDF page proofs are e-mailed by the 
Publisher to the corresponding author for final approval. 
Authors are responsible for all statements made in their 
work, including changes made by the copy editor.
12. Reprints
Authors receive 20 stapled offprints of their articles free of 
charge, which will be sent by the Editorial Office to the cor-
responding author. Professional reprints (which include a 
cover page for the article) may be ordered from the Publisher 
at prices based on the cost of production. A reprint order 
form can be downloaded from the journal website at www.
tjog-online.com.
13. Copyright
Authors submitting a manuscript do so with the understand-
ing that if it is accepted for publication, the exclusive copy-
right of the paper shall be transferred to the Taiwan 
Association of Obstetrics and Gynecology. Published manu-
scripts become the permanent property of the Taiwan 
Association of Obstetrics and Gynecology, and may not be 
published elsewhere without written permission. Authors 
wishing to use material from their own papers published in 
the Journal should apply to the Association for permission. 
Non-authors should first obtain permission in writing from 
the corresponding author and enclose this with their request 
to the Association.
